By
Drug Target Review2025-08-11T13:30:48
University of Chicago researchers have developed a scalable nanoparticle platform that self-assembles with just a temperature change – enabling safe, solvent-free delivery of proteins and RNA for vaccines and therapies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2023-06-20T12:34:32
Sponsored by NanoTemper Technologies
2025-04-22T14:58:00
Sponsored by Takara Bio USA
Site powered by Webvision Cloud